Company Profiles

driven by the PitchBook Platform

Acylin Therapeutics

Description

Developer of drugs for cancer treatment. The company engages in research and development therapeutics medicines and drugs for oncology, cancer, tumors and other inflammatory diseases.

2009

Founded

PRIVATE

Status

2ndary - Private

Latest Deal Type

$1.04M

Latest Deal Amount

$4.4M

Total Amount Raised

6

Investors

Description

Developer of drugs for cancer treatment. The company engages in research and development therapeutics medicines and drugs for oncology, cancer, tumors and other inflammatory diseases.

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Primary Office

1616 Eastlake Avenue Suite 203 Seattle, WA 98102United States +1 (206) 957-7300
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Acylin Therapeutics's full profile, request a free trial.

    Acylin Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Acylin Therapeutics Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Acylin Therapeutics Investors (6)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    AcceleratorVenture CapitalMinority000 0000000 0000
    Alexandria Real Estate EquitiesReal EstateMinority000 0000000 0000
    Amgen VenturesCorporate Venture CapitalMinority000 0000000 0000
    Fast Forward at Johns Hopkins UniversityAccelerator/Incubator000 0000000 0000
    OVP Venture PartnersVenture CapitalMinority000 0000000 0000
    Accelerator Venture Capital
    Alexandria Real Estate Equities Real Estate
    Amgen Ventures Corporate Venture Capital
    Fast Forward at Johns Hopkins University Accelerator/Incubator
    OVP Venture Partners Venture Capital

    Acylin Therapeutics Executive Team (2)

    NameTitleBoard
    Seat
    Contact
    Info
    Suresh Jain Ph.DCo-Founder, President & Chief Operating Officer
    Roydon PriceCo-Founder
    Suresh Jain Ph.D Co-Founder, President & Chief Operating Officer
    Roydon Price Co-Founder

    Acylin Therapeutics Board Members (5)

    NameRepresentingRoleSinceContact
    Info
    Carl WeissmanAcceleratorChairman000 0000
    Chad Waite Jr.OVP Venture PartnersManaging Director000 0000
    Lee Babiss Ph.DPharmaceutical Product DevelopmentChief Scientific Officer and Executive Vice President of Global Laboratory Services000 0000
    Lindsay RayleAcceleratorChief Financial Officer, Controller & Vice President, Operations000 0000
    Peter DiStefano Ph.DSelfBoard Member000 0000
    Carl Weissman Chairman Accelerator
    Chad Waite Jr. Managing Director OVP Venture Partners
    Lee Babiss Ph.D Chief Scientific Officer and Executive Vice President of Global Laboratory Services Pharmaceutical Product Development
    Lindsay Rayle Chief Financial Officer, Controller & Vice President, Operations Accelerator
    Peter DiStefano Ph.D Board Member Self
    Request full access to PitchBook